• 1
    Douglass J, McKinzie AA, Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci. 1995; 15(3 Pt 2): 247181.
  • 2
    Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature. 1998; 393(6680): 726.
  • 3
    Lambert PD, Couceyro PR, McGirr KM, Dall Vechia SE, Smith Y, Kuhar MJ. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse. 1998; 29(4): 2938.
  • 4
    Hunter RG, Kuhar MJ. CART peptides as targets for CNS drug development. Curr Drug Targets CNS Neurol Disord. 2003; 2(3): 2015.
  • 5
    Vicentic A, Jones DC. The CART (cocaine- and amphetamine-regulated transcript) system in appetite and drug addiction. J Pharmacol Exp Ther. 2007; 320(2): 499506.
  • 6
    Koylu EO, Balkan B, Kuhar MJ, Pogun S. Cocaine and amphetamine regulated transcript (CART) and the stress response. Peptides. 2006; 27(8): 195669.
  • 7
    Stanek LM. Cocaine- and amphetamine related transcript (CART) and anxiety. Peptides. 2006; 27(8): 200511.
  • 8
    Chaki S, Kawashima N, Suzuki Y, Shimazaki T, Okuyama S. Cocaine- and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents. Eur J Pharmacol. 2003; 464(1): 4954.
  • 9
    Orsetti M, Di Brisco F, Canonico PL, Genazzani AA, Ghi P. Gene regulation in the frontal cortex of rats exposed to the chronic mild stress paradigm, an animal model of human depression. Eur J Neurosci. 2008; 27(8): 215664. Epub 2008 Mar 25.
  • 10
    Iliff JJ, Alkayed NJ, Gloshani KJ, Traystman RJ, West GA. Cocaine- and amphetamine-regulated transcript (CART) peptide: a vasoactive role in the cerebral circulation. J Cereb Blood Flow Metab. 2005; 25(10): 137685.
  • 11
    Matsumura K, Tsuchihashi T, Abe I. Central human cocaine- and amphetamine-regulated transcript peptide 55–102 in creases arterial pressure in conscious rabbits. Hypertension. 2001; 38(5): 1096100.
  • 12
    Xu Y, Zhang W, Klaus J, Young J, Koerner I, Sheldahl LC, Hurn PD, Martínez-Murillo F, Alkayed NJ. Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection. Proc Natl Acad Sci U S A. 2006; 103(39): 1448994.
  • 13
    Kobayashi Y, Jimenez-Krassel F, Li Q, Yao J, Huang R, Ireland JJ, Coussens PM, Smith GW. Evidence that cocaine- and amphetamine-regulated transcript is a novel intraovarian regulator of follicular atresia. Endocrinology. 2004; 145(11): 537383.
  • 14
    Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 2005; 434(7032): 51420.
  • 15
    Rogge G, Jones D, Hubert GW, Lin Y, Kuhar MJ. CART peptides: regulators of body weight, reward and other functions. Nat Rev Neurosci. 2008; 9(10): 74758.
  • 16
    Thim L, Kristensen P, Nielsen PF, Wulff BS, Clausen JT. Tissue-specific processing of cocaine- and amphetamine-regulated transcript peptides in the rat. Proc Natl Acad Sci U S A. 1999; 96 27227.
  • 17
    Stein J, Shah R, Steiner DF, Dey A. RNAi-mediated silencing of prohormone convertase (PC) 5/6 expression leads to impairment in processing of cocaine- and amphetamine-regulated transcript (CART) precursor. Biochem J. 2006; 400: 20915.
  • 18
    Dylag T, Kotlinksa J, Rafalski P, Pachuta A, Silberring J. The activity of CART peptide fragments. Peptides. 2006; 27: 192633.
  • 19
    Bannon AW, Seda J, Carmouche M, Francis JM, Jarosinski MA, Douglass J. Multiple behavioral effects of cocaine- and amphetamine-regulated transcript (CART) peptides in mice: CART 42-89 and CART 49-89 differ in potency and activity. J Pharmacol Exp Ther. 2001; 299(3): 10216.
  • 20
    Koylu EO, Couceyro PR, Lambert PD, Kuhar MJ. Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J Comp Neurol. 1998; 391: 11532.
  • 21
    Koylu EO, Couceyro PR, Lambert PD, Ling NC, DeSouza EB, Kuhar MJ. Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland. J Neuroendocrinol. 1997; 9(11): 82333.
  • 22
    Dun SL, Chianca DA Jr, Dun NJ, Yang J, Chang JK. Differential expression of cocaine- and amphetamine-regulated transcript-immunoreactivity in the rat spinal preganglionic nuclei. Neurosci Lett. 2000; 294 1436.
  • 23
    Ekblad E. CART in the enteric nervous system. Peptides. 2006; 27: 202430.
  • 24
    Wierup N, Kuhar MJ, Nilsson BO, Mulder H, Ekblad E, Sundler F. Cocaine- and amphetamine-regulated transcript (CART) is expressed in several islet cell types during rat development. J Histochem Cytochem. 2004; 52: 16977.
  • 25
    Ekblad E, Kuhar M, Wierup N, Sundler F. Cocaine- and amphetamine-regulated transcript: distribution and function in rat gastrointestinal tract. Neurogastroenterol Motil. 2003; 15: 54557.
  • 26
    Wierup N, Gunnarsdottir A, Ekblad E, Sundler F. Characterization of CART-containing neurons and cells in the porcine pancreas, gastro-intestinal tract, adrenal and thyroid glands. BMC Neurosci. 2007; 8: 51.
  • 27
    Couceyro PR, Koylu EO, Kuhar MJ. Further studies on the anatomical distribution of CART by in situ hybridization. J Chem Neuroanat. 1997; 12: 22941.
  • 28
    Dun NJ, Dun SL, Kwok EH, Yang J, Chang J. Cocaine- and amphetamine-regulated transcript-immunoreactivity in the rat sympatho-adrenal axis. Neurosci Lett. 2000; 283: 97100.
  • 29
    Jensen PB, Kristensen P, Clausen JT, Judge ME, Hastrup S, Thim L, Wulff BS, Foged C, Jensen J, Holst JJ, Madsen OD. The hypothalamic satiety peptide CART is expressed in anorectic and non-anorectic pancreatic islet tumors and in the normal islet of Langerhans. FEBS Lett. 1999; 447: 13943.
  • 30
    Vicentic A, Dominguez G, Hunter RG, Philpot K, Wilson M, Kuhar MJ. Cocaine- and amphetamine-regulated transcript peptide levels in blood exhibit a diurnal rhythm: regulation by glucocorticoids. Endocrinology. 2004; 145(9): 411924.
  • 31
    Wierup N, Richards WG, Bannon AW, Kuhar MJ, Ahrén B, Sundler F. CART knockout mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight. Regul Pept. 2005; 129(1–3): 20311.
  • 32
    Ahn JD, Dubern B, Lubrano-Berthelier C, Clement K, Karsenty G. Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency. Endocrinology. 2006; 147(7): 3196202.
  • 33
    Singh MK, Elefteriou F, Karsenty G. Cocaine and amphetamine-regulated transcript may regulate bone remodeling as a circulating molecule. Endocrinology. 2008; 149(8): 393341.
  • 34
    Guérardel A, Tankó LB, Boutin P, Christiansen C, Froguel P. Obesity susceptibility CART gene polymorphism contributes to bone remodeling in postmenopausal women. Osteoporos Int. 2006; 17(1): 1567.
  • 35
    Rondini TA, Baddini SP, Sousa LF, Bittencourt JC, Elias CF. Hypothalamic cocaine- and amphetamine-regulated transcript neurons project to areas expressing gonadotropin releasing hormone immunoreactivity and to the anteroventral periventricular nucleus in male and female rats. Neuroscience. 2004; 125(3): 73548.
  • 36
    Kappeler L, Gautron L, Layé S, Dantzer R, Zizzari P, Epelbaum J, Bluet-Pajot MT. Pituitary cocaine- and amphetamine-regulated transcript expression depends on the strain, sex and oestrous cycle in the rat. J Neuroendocrinol. 2006; 18(6): 42633.
  • 37
    Riggs BL, Khosla S, Melton LJ 3rd. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002; 23(3): 279302.
  • 38
    Perrien DS, Akel NS, Edwards PK, Carver AA, Bendre MS, Swain FL, Skinner RA, Hogue WR, Nicks KM, Pierson TM, Suva LJ, Gaddy D. Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology. 2007; 148(4): 165465.
  • 39
    Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB, Zhou H, Zallone A, Sairam MR, Kumar TR, Bo W, Braun J, Cardoso-Landa L, Schaffler MB, Moonga BS, Blair HC, Zaidi M. FSH directly regulates bone mass. Cell. 2006; 125(2): 24760.
  • 40
    Allan CM, Kalak R, Dunstan CR, McTavish KJ, Zhou H, Handelsman DJ, Seibel MJ. Follicle-stimulating hormone increases bone mass in female mice. Proc Natl Acad Sci U S A. 2010; 107(52): 2262934.
  • 41
    Pepe A, Ferlin A, Gianesello L, Facciolli A, Agoulnik AI, Foresta C. INSL3 plays a role in the balance between bone formation and resorption. Ann N Y Acad Sci. 2009; 1160: 21920.
  • 42
    Ferlin A, Pepe A, Gianesello L, Garolla A, Feng S, Giannini S, Zaccolo M, Facciolli A, Morello R, Agoulnik AI, Foresta C. Mutations in the insulin-like factor 3 receptor are associated with osteoporosis. J Bone Miner Res. 2008; 23(5): 68393.
  • 43
    Ivell R, Hartung S, Anand-Ivell R. Insulin-like factor 3: where are we now?. Ann N Y Acad Sci. 2005; 1041: 48696.
  • 44
    Gambineri A, Patton L, De Iasio R, Palladoro F, Pagotto U, Pasquali R. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome. Clin Endocrinol Metab. 2007; 92(6): 206673.
  • 45
    Lima FB, Henderson JA, Reddy AP, Tokuyama Y, Hubert GW, Kuhar MJ, Bethea CL. Unique responses of midbrain CART neurons in macaques to ovarian steroids. Brain Res. 2008; 1227: 7688.
  • 46
    Akhmadeev AV. Localization of CART-positive neurons in the amygdaloid body and the relationship between their immunoreactivity and the sex steroid level. Neurosci Behav Physiol. 2010; 40(4): 4359.
  • 47
    van Casteren JI, Schoonen WG, Kloosterboer HJ. Development of time-resolved immunofluorometric assays for rat follicle-stimulating hormone and luteinizing hormone and application on sera of cycling rats. Biol Reprod. 2000; 62(4): 88694.
  • 48
    Everts V, de Vries TJ, Helfrich MH. Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. Biochim Biophys Acta. 2009; 1792(8): 75765.
  • 49
    Chappard D, Petitjean M, Alexandre C, Vico L, Minaire P, Riffat G. Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts. J Bone Miner Res. 1991; 6(7): 67380.
  • 50
    Laan RF, Buijs WC, van Erning LJ, Lemmens JA, Corstens FH, Ruijs SH, van de Putte LB, van Riel PL. Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content. Calcif Tissue Int. 1993; 52(1): 59.
  • 51
    Bartell SM, Isales CM, Baile CA, Kuhar MJ, Hamrick MW. CART deficiency increases body weight but does not alter bone strength. J Musculoskelet Neuronal Interact. 2008; 8(2): 14653.
  • 52
    Kastin AJ, Akerstrom V. Entry of CART into brain is rapid but not inhibited by excess CART or leptin. Am J Physiol. 1999; 277(5 Pt 1): E9014.
  • 53
    Stanley SA, Small CJ, Murphy KG, Rayes E, Abbott CR, Seal LJ, Morgan DG, Sunter D, Dakin CL, Kim MS, Hunter R, Kuhar M, Ghatei MA, Bloom SR. Actions of coc aine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Res. 2001; 893(1–2): 18694.
  • 54
    Parent AS, Lebrethon MC, Gérard A, Vandersmissen E, Bourguignon JP. Leptin effects on pulsatile gonadotropin releasing hormone secretion from the adult rat hypothalamus and interaction with cocaine and amphetamine regulated transcript peptide and neuropeptide Y. Regul Pept. 2000; 92(1–3): 1724.
  • 55
    Lebrethon MC, Vandersmissen E, Gérard A, Parent AS, Junien JL, Bourguignon JP. In vitro stimulation of the prepubertal rat gonadotropin-releasing hormone pulse generator by leptin and neuropeptide Y through distinct mechanisms. Endocrinology. 2000; 141(4): 14649.
  • 56
    Yarram SJ, Perry MJ, Christopher TJ, Westby K, Brown NL, Lamminen T, Rulli SB, Zhang FP, Huhtaniemi I, Sandy JR, Mansell JP. Luteinizing hormone receptor knockout (LuRKO) mice and transgenic human chorionic gonadotropin (hCG)-overexpressing mice (hCG alphabeta+) have bone phenotypes. Endocrinology. 2003; 144(8): 355564.